Kohei Shitara/X
Mar 4, 2025, 08:14
Kohei Shitara: DESTINY-Gastric04 demonstrated significantly prolonged OS in gastric cancer
Kohei Shitara, Medical Oncologist at National Cancer Center Hospital East, Japan, shared a post on X:
“DESTINY-Gastric04 demonstrated significantly prolonged OS with T-DXd vs. PTX+RAM in HER2+ gastric cancer.
A major advancement for patients! Congratulations to all involved!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 1, 2025, 19:24
Aug 1, 2025, 19:14
Aug 1, 2025, 18:32